Gattefossé Opens Manufacturing Facility in Lufkin, Texas

Gattefossé, a provider of specialty ingredients and formulation solutions for personal care and pharmaceutical industries, has opened its new manufacturing facility in Lufkin, Texas.

This investment represents a pivotal milestone in Gattefossé’s global growth strategy, expanding its production capabilities in North America and reinforcing its position as a top international supplier.

The Lufkin plant is dedicated to lipid-based excipients and was designed with the dual ambition of increasing production capacity and reinforcing Gattefossé’s presence in North America, a region that is both a leading market and a global trendsetter for pharmaceuticals and personal care.

This new facility represents the most significant investment in the Group’s history. It was conceived as a long-term commitment to customers, offering increased production capacity, secured supply chains, and optimized lead times, all while maintaining the same quality standards delivered across the globe.

In March 2025, the Lufkin plant was awarded three certifications—ISO 9001, EFfCI GMP, and EXCiPACT—recognizing Gattefossé’s rigorous approach to quality, safety, and compliance in both pharmaceutical and cosmetic ingredient manufacturing. In addition to efficiency and performance, the site was designed according to LEED certification criteria, ensuring it meets the highest environmental standards.

The inauguration of the Lufkin site is a new chapter in Gattefossé’s industrial development. By adding a U.S.-based manufacturing hub, Gattefossé now secures an industrial footprint across three continents. This global network ensures resilient supply chains, greater proximity to customers, and consistent product quality worldwide.

Ségolène Moyrand-Gros, President of Gattefossé Group, said: “The opening of our new plant in Lufkin marks a major milestone in our company’s journey. This investment is not about short-term gain, it is about building a foundation that will serve our customers for decades to come. Choosing the United States was a strategic decision: this region is not only a leading market but also a global trendsetter in pharmaceuticals and personal care. This plant is more than a building; it is a promise to grow, to innovate, and to create value together with confidence, responsibility, and passion.”